Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Timing your investments in stocks vs bonds can significantly impact returns. Learn when to make your moves.
13,124 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
A large hedge fund reduced its stake in InterDigital (IDCC) by selling 125,230 shares, worth about $44.28 million. Th...
Talkspace stock surged today as investors responded to stronger-than-expected results and improving unit economics. T...
EPAM Systems sank this week after reporting earnings that beat the street but offered cautious 2026 guidance. This ar...
When a CEO unloads a big chunk of stock, investors take note. This article digs into sentinelone's sold over 39,000 s...
If you’re hunting for a lifelong holding, the dividend track record of Medtronic is hard to ignore. This piece explai...
Axsome's 2025 earnings season is shaping up as a pivotal moment for investors. This article breaks down what to expec...
News of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
Snap Inc has faced a severe share-price drop, but a mix of AR hardware progress, AI-enhanced ads, and international g...
Salesforce posted a stronger-than-expected quarter, delivering an EPS beat and stronger cash flow. The company unveil...
A major investment manager has built a sizable position in CCC Intelligent Solutions with a $15 million purchase. Thi...
IonQ stock surged today after the company issued a revenue forecast that beat expectations, sparking a rally in the q...